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Bjørn Auestad, PhD; Thor Edvardsen , MD, PhD; Kristin Moberg Aakre , MD, PhD; Stein Ørn , MD, PhD
BACKGROUND: Postexercise cardiac troponin levels show considerable interindividual variations. This study aimed to identify 
the major determinants of this postexercise variation in cardiac troponin I (cTnI) following 3 episodes of prolonged high- 
intensity endurance exercise.
METHODS AND RESULTS: Study subjects were recruited among prior participants in a study of recreational cyclists completing a 
91- km mountain bike race in either 2013 or 2014 (first race). In 2018, study participants completed a cardiopulmonary exercise 
test 2 to 3 weeks before renewed participation in the same race (second race). Blood was sampled before and at 3 and 24 
hours following all exercises. Blood samples were analyzed using the same Abbot high- sensitivity cTnI STAT assay. Fifty- nine 
individuals (aged 50±9 years, 13 women) without cardiovascular disease were included. Troponin values were lowest before, 
highest at 3 hours, and declining at 24 hours. The largest cTnI difference was at 3 hours following exercise between the most 
(first race) (cTnI: 200 [87– 300] ng/L) and the least strenuous exercise (cardiopulmonary exercise test) (cTnI: 12 [7– 23] ng/L; 
P<0.001). The strongest correlation between troponin values at corresponding times was before exercise (r=0.92, P<0.0001). 
The strongest correlations at 3 hours were between the 2 races (r=0.72, P<0.001) and at 24 hours between the cardiopul-
monary exercise test and the second race (r=0.83, P<0.001). Participants with the highest or lowest cTnI levels showed no 
differences in race performance or baseline echocardiographic parameters.
CONCLUSIONS: The variation in exercise- induced cTnI elevation is largely determined by a unique individual cTnI response that 
is dependent on the duration of high- intensity exercise and the timing of cTnI sampling.
REGISTRATION: URL: https://www.clini caltr ials.gov; Unique identifier: NCT02166216.
Key Words: biomarkers ■ exercise physiology ■ troponin
E levated cardiac troponin (cTn) is a marker of myocardial damage, and high levels are associ-ated with an adverse prognosis in both patients 
with and without known coronary artery disease.1,2 
It has been known for >3 decades that prolonged 
strenuous exercise causes an increase in the cTn val-
ues in healthy individuals. The exercise- induced cTn 
elevation in healthy individuals is considered a be-
nign response to exercise.3 However, recent studies 
found independent associations between exercise- 
induced cTn elevation, adverse cardiovascular 
events, and obstructive coronary artery disease.4,5 
These findings suggest a potential diagnostic role for 
postexercise cTn assessment. However, no cTn level 
cutoffs to differentiate a benign from a pathologic 
cTn elevation have been identified. This is possibly 
because of the considerable interindividual varia-
tions in cTn values, and a limited understanding of 
the mechanisms causing exercise- induced troponin 
elevation in healthy individuals. A better understand-
ing of the determinants of the exercise- induced cTn 
elevation might pave the way for the potential use 
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of exercise- induced cTn elevation in a diagnostic 
setting.
Previous studies have identified baseline cTn, exer-
cise intensity, and duration of exercise as predictors of 
the exercise- induced cTn elevation.6– 9 Recent studies 
suggest that the duration of elevated heart rate and 
blood pressure before exercise might be predictors 
of the exercise- induced cTn response.10 However, the 
current prediction models only explain part (<36%) of 
the physiological cTn variation,9 underlining the possi-
bility that other individual factors play a more important 
role. This is the first study to evaluate the individual re-
producibility of exercise- induced cTn elevation follow-
ing physical efforts separated by >4  years. The aim 
of this study was to identify the major determinants 
of individual variation in the cTn response to exercise, 
with a particular focus on the impact of the individual 
cTn response in relation to workload and timing of cTn 
sampling following exercise.
METHODS
In 2018, study individuals were recruited from a pool 
of previous participants in the NEEDED (North Sea 
Race Endurance Study) in either 2013 or 2014.9,11 All 
participants had participated in the 91- km leisure sport 
mountain bike race (the North Sea Race) in either 2013 
or 2014 (T0). In 2018, the recruited study participants 
were examined by a cardiopulmonary exercise (CPX) 
test (T1), 2 to 3 weeks before a renewed participation 
in the North Sea Race (T2). There was a comprehen-
sive measurement of physiological parameters dur-
ing the 2018 race (T2). Blood was sampled at similar 
time points (before and at 3 and 24  hours following 
the race) and analyzed using the same high- sensitivity 
cardiac troponin I (cTnI) assay at the 2 races (T0 and 
T2) and the CPX test (T1). Coronary computed to-
mography angiography was performed following T2 
to ensure that no individual had obstructive coronary 
artery disease. The present study complies with the 
Declaration of Helsinki, all participants signed informed 
consent forms before the study, and the regional eth-
ics committee approved the study (REK no. 2013/550 
and no. 2018/63). The data that support the findings of 
this study are available from the corresponding author 
upon reasonable request.
Study Subjects and Baseline 
Measurements
Only healthy subjects without obstructive coronary 
artery disease on coronary computed tomography 
angiography in 2013 or 2014 were eligible for the pre-
sent study.12 Only data from individuals participating 
in all 3 exercises were included in the final analysis 
(Figure 1). All study subjects underwent a thorough ex-
amination at inclusion in 2018, including a detailed his-
tory, blood investigations, ECG, blood pressure, and 
CLINICAL PERSPECTIVE
What Is New?
• The magnitude of exercise- induced troponin el-
evation is largely determined by a reproducible, 
unique individual troponin response.
• This individual response is not related to altera-
tions in physical performance or baseline echo-
cardiographic parameters.
What Are the Clinical Implications?
• The individual troponin response needs to 
be included in the interpretation of individual 
exercise- induced troponin values.
• These large physiological interindividual varia-
tions in the exercise- induced troponin response 
requires the establishment of individual troponin 
reference values if the response is to be used 
for diagnostic purposes.
Nonstandard Abbreviations and Acronyms
CPX cardiopulmonary exercise test
cTn cardiac troponin
cTnI cardiac troponin I
RPP rate pressure product
Figure 1. Flowchart of the study.
CPX indicates cardiopulmonary exercise; T0, recruitment race; 
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echocardiographic examination. Twelve- lead ECGs 
were taken at baseline and at 3 and 24  hours after 
exercise. Each participant answered questionnaires 
about symptoms after all exercises at all 3 time points. 
Noninvasive blood pressure was measured 3 times 
in a sitting position with an automated blood pres-
sure monitor. The average of the 2 last measurements 
was used to calculate blood pressure. For an assess-
ment of the amount of daily exercise, the International 
Activity Questionnaire was used.13 The data from the 
International Activity Questionnaire were used to cal-
culate the metabolic equivalent hours per week for 
each participant.
Estimation of Total and Cardiac Work
Except for the time taken to complete the race, there 
were no data about the total and cardiac work from 
the recruitment race (T0). During both the CPX test 
(T1) and the 2018 race (T2), power meters were used 
to assess the total work performed. Work during the 
CPX test (T1) was measured by a Cyclus 2 electroni-
cally braked ergo trainer (RBM Elektronik- Automation, 
Leipzig, Germany).14 Each participant used their own 
bikes fitted to the Cyclus2 during the CPX test. Work 
performed during the 2018 race (T2) (n=40) was 
measured continuously with Stages power meters 
(StagesPower, Boulder, CO).15 The Stages power me-
ters were mounted on the bikes by replacing the origi-
nal crank arm of the left side with a crank arm with a 
Stages power sensor. The rate pressure product (RPP) 
was used to estimate cardiac work during the exer-
cise.16 RPP was calculated as either mean or maximal 
RPP. Mean RPP was calculated as mean systolic blood 
pressure during exercise multiplied by mean heart rate, 
whereas maximum RPP was calculated as the high-
est measured systolic blood pressure multiplied by the 
maximal heart rate. Both during the CPX test (T1) and 
the 2018 race (T2), heart rate was measured continu-
ously by chest straps and similar heart rate monitors in 
all the study subjects (Garmin Forerunner 935; Garmin, 
Olathe, KS). During the CPX test (T1), blood pressure 
was measured automatically using a Tango M2 Stress 
test monitor (Suntech Medical, Morrisville, NC). During 
the 2018 race (T2), blood pressure was measured 
manually on the right arm with a Heine G5, G7, or XXL 
LF- T (Heine, Herrsching, Germany) at 4 pit stops at the 
maximum and minimum anticipated efforts at the top 
and bottom at the 2 largest hills of the race after 34, 41, 
69, and 76 km (Figure S1). A detailed description of the 
CPX test can be found in Data S1.
Blood Sampling
Blood was sampled at similar time points for all 3 ex-
ercises (T0, T1, and T2): the day before (baseline) the 
exercise and at 3 and 24 hours following the exercise. 
Blood samples were taken from the antecubital vein 
in a sitting position after a resting period of >5 min-
utes. Blood samples were stored at 4 ºC and analyzed 
within 24 hours of sampling.
Troponin Measurements
The same high- sensitivity cTnI assay (STAT) from 
Abbott Diagnostics was used for the measurement of 
troponin during all 3 events: T0, T1, and T2. The assay 
was analyzed on an Architect SR2000i (Abbott) for all 
sampling points. In 2013/2014 (T0) and 2018 (T1 and 
T2), the reported results were at or more than the limit 
of detection (1.6  ng/L) and limit of blank (0.9  ng/L). 
The cTnI assay had a total coefficient of variation of 
10% at 6 ng/L, 7% at 27 ng/L, and 5% at 140 ng/L. 
Overall 99th percentile was 26 ng/L (men: 34 ng/L and 
women: 16 ng/L).17
Echocardiographic Assessment
Two GE Vivid E 95 systems (Vingmed, Horten, Norway) 
were used for the echocardiographic assessment per-
formed at inclusion (T1). Comprehensive imaging pro-
tocols were applied, with complete coverage of both 
atria and ventricles, including parasternal and apical 
views, and adequate high frame rates to allow high- 
quality postprocessing, including speckle tracking 
and both global and regional strain analysis. An ex-
perienced medical doctor, blinded to the clinical data 
and exercise information, performed off- line post-
processing on a GE EchoPAC (GE Healthcare, Horten, 
Norway). All parameters were calculated according to 
the recommendations of the European Association of 
Cardiovascular Imaging.18
Statistical Analysis
Normally distributed continuous variables are reported 
as mean±standard deviation, whereas continuous 
variables with markedly skewed distributions are re-
ported as the median and interquartile range (25th– 
75th percentile). The Shapiro- Wilk test was used to test 
for normality. For changes over time, a paired t test or 
Wilcoxon signed rank test was used as appropriate. 
Spearman correlation was used to study bivariate as-
sociations. A 2- tailed P value <0.05 was considered 
significant. A linear mixed effects model with random 
intercept was used for estimation of between- group 
differences. Differences were estimated at each time 
point (baseline, +3 hours, and +24 hours) among the 3 
groups, T0, T1, and T2. Multiple linear regression with a 
backward elimination was used with postexercise cTnI 
values at 3 and 24 hours after the CPX test and the 
race in 2018 as dependent values. Age, sex, duration of 
exercise, and systolic blood pressure at baseline were 
selected a priori.9,19,20 Because of markedly skewed 
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a natural logarithm. Based on the correlation analysis 
with cTnI as the dependent variable, explanatory vari-
ables with P<0.05 were included in the models. The 
same variables of effort were selected for both T1 and 
T2. Corresponding values from T0 and T1 or T2 were 
added to investigate if these variables would have a dif-
ferent influence on exercise- induced cTn. The statisti-
cal software programs SPSS version 26 (IBM, Armonk, 
NY) and GraphPad Prism 9 (GraphPad Software, San 
Diego, CA) were used for statistical analysis and gen-
erating the graphs.
RESULTS
Data from a total of 59 healthy cyclists (aged 
50±9 years, 13 women) were included in the present 
analysis. There were no major abnormal echocardio-
graphic findings at baseline (Table 1), and there was no 
obstructive coronary artery disease on coronary com-
puted tomography angiography following T2. None of 
the participants reported symptoms or had ECG find-
ings suggestive of cardiac disease.
Exercise Characteristics
There were significant differences in exercise work-
load between the CPX test (T1) and the 2018 race (T2) 
(Table 2). The exercise workload was higher in the 2018 
race (T2) compared with the CPX test (T1); the duration 
of high- intensity exercise was longer in the race, and 
the mean heart rate, peak power output, the peak and 
mean systolic blood pressure, and the peak and mean 
RPP were all higher in the race (T2). In contrast, there 
was no difference in maximal heart rate, and the mean 
power output and mean systolic pressure were lower 
during T2 compared with T1 (Table 2).
For the recruitment race (T0), the only measurement 
of exercise intensity was the duration of the race. The 
duration was shorter (P<0.001) in T0 (3.6 [3.4– 4.0] hours) 
than in T2 (4.2 [3.6– 4.6] hours), at least partly because 
of interrupted exercise because of the four 2- minute pit 
stops to assess the blood pressure. The race course 
and the weather conditions were the same during T0 
and T2, reflected by the same race duration for all par-
ticipants in the race: mean 4.2 hours in 2018 (n=2650) 
compared with mean 4.1 hours in 2013/2014 (n=8763).
Exercise- Induced cTnI Profile
The cTnI values had the same profile following all 3 
rounds of exercise (T0, T1, and T2): the lowest cTnI lev-
els were at baseline, the highest at 3 hours after exer-
cise, with declining values at 24 hours (Figure 2). The 
3- hour exercise- induced cTnI levels were higher after 
T2 (77 [37– 128] ng/L) than after T1 (12 [7– 23] ng/L), and 
were highest after T0 (200 [87– 300] ng/L) (P<0.001). 
A similar pattern was seen for the 24- hour values, T1 
(5 [3– 9] ng/L), T2 (16 [8– 32] ng/L), and T0 (34 [18– 85] 
ng/L) (P<0.001).
Correlation Between Physical 
Measurements and Exercise- Induced cTnI 
Values
There was no correlation between baseline echocar-
diographic parameters and cTnI levels, and no correla-
tion between cTnI levels and duration of exercise above 
the heart rate and power thresholds. A summary of the 
main findings and the basic parameters are presented 
in Table 2. RPP was found to have a significant correla-
tion with exercise- induced cTnI value at both T1 and 
T2. Peak systolic pressure was significantly correlated 
Table 1. Baseline Characteristics and Physical 
Measurements During the CPX Test and the 2018 Race




Male sex, n (%) 46 (74%)
Age, y 50.3±9.6 31– 77
Body mass index, kg/m2 24.9 (23.3– 27.1) 21.4– 33.6
Systolic blood pressure, mm Hg 135 (122– 146) 110– 175
Diastolic blood pressure, mm Hg 81 (74– 89) 61– 104
Resting heart rate, bpm 60±10 41– 92
Waist circumference, cm 86 (81– 93) 72– 107
Years of endurance training 10 (7– 21) 0– 50
Total MET h, MET h/wk 61 (47– 102) 15– 359
CPX test, T1
Vo2Max, mL/min per kg 41.3±8.3 24.0– 57.1
Power at lactate threshold, W 200±47 80– 300
Heart rate lactate threshold, 
bpm
162±13 134– 200
Echocardiographic findings at baseline
LV measurements
LV mass index, 2D, g/m2 87.1±14.2 63.0– 129.0
LV septum, mm 10.4±1.1 7.0– 13.0
LV volume, 3D, mL/m2
Diastole 84.4±18.2 59.7– 129.5
Systole 35.3±8.3 19.4– 57.4
E/A ratio 1.4±0.4 0.9– 2.5
LV ejection fraction, 3D, % 58.3±3.7 51.0– 67.0
LV GLS, % 20.2±2.2 15.9– 25.5
RV measurements
RV volume, mL/m2, 3D
Diastole 75.3±14.7 51.0– 116.0
Systole 40.2±9.8 24.0– 69.0
RV 3 segment GLS, % 26.8±3.8 14.4– 34.3
Normally distributed values are reported as mean±SD and markedly 
skewed values are reported as median (25th– 75th percentile) unless 
indicated otherwise. CPX indicates cardiopulmonary exercise; GLS, global 
longitudinal strain; LV, left ventricle; MET, metabolic equivalent; RV, right 
ventricle; Vo2Max, maximum oxygen consumption; 2D, two- dimensional; 
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with the exercise- induced cTnI value at 24 hours fol-
lowing the CPX test (r=0.29, P=0.003) and reached 
borderline significance at 24 hours following the race 
(T2) (r=0.25, P=0.06).
Low- Versus High- cTnI Responders
Figure  3 displays the consistency in the rankings of 
cTnI values following the 2 races T0 and T2. Individuals 
were either classified as low- or high- cTnI responders 
depending on their cTnI value 3 hours after exercise in 
the recruitment race (T0). Low responders were defined 
as individuals with a cTnI level within the first quartile 
after T0, whereas high responders were defined as in-
dividuals with a cTnI level in the highest quartile in T0. 
There was no difference in the physical performance 
or echocardiographic parameters after the 2018 race 
Figure 2. Cardiac troponin I (cTnI), at baseline, 3 h, and 24 h, after the cardiopulmonary exercise test in 2018 (T1), the North 
Sea Race in 2018 (T2), and the North Sea Race recruitment race in either 2013 or 2014 (T0).
Scale is log10- transformed. Dotted lines indicate the 99th percentile of the high- sensitivity cTnI assay (26 ng/L).
Figure 3. Consistency in ranking of cardiac troponin I (cTnI) values following the recruitment race (the North Sea Race in 
either 2013 or 2014) and the 2018 North Sea Race.
Low responders are defined as individuals with a cTnI value within the first quartile (Q1) of the recruitment race (T0), whereas high 
responders are defined as individuals with a cTnI value within the highest quartile (Q4) of the recruitment race (T0). The graph displays 
the number of individuals in each of the 4 quartiles based on the cTnI values achieved in the 2018 race (T2). T0 indicates recruitment 
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between low- and high- cTnI responders. Following the 
race in 2018, none of the low responders in the recruit-
ment race (T0) were classified as high responders in the 
second race (T2), and none of the high responders were 
classified as low responders in the second race (T2).
Correlation Between cTnI Levels at 
Corresponding Time Points During the 3 
Exercises
In the individual subjects, there were strong correla-
tions between cTnI values from the 2 races (T0 and T2) 
and the CPX test (T1) at all corresponding time points 
(Figure 4). The strongest correlations between cTnI val-
ues were observed at baseline (ie, 24 hours before the 
exercise). Following exercise, the strongest correlation 
at 3 hours was between the 2 races (r=0.72, P<0.001) 
and at 24 hours between the CPX test and the second 
race (r=0.83, P<0.001). The weakest correlations were 
between the recruitment race (T0) and the CPX test 
(T1) at both 3 and 24 hours following exercise.
Linear Mixed Effects
Differences between expected values are presented 
in Table 3. The largest difference in expected values 
Figure 4. Scatterplot shows individual cardiac troponin I (cTnI) response at baseline, 3 h, and 24 h after the cardiopulmonary 
exercise (CPX) test in 2018 (T1), the 2018 race (T2), and the recruitment race in either 2013 or 2014 (T0).
Spearman bivariate correlations were used to assess the correlations between time points. Dotted lines indicate the 99th percentile 




 http://ahajournals.org by on Septem
ber 23, 2021
J Am Heart Assoc. 2021;10:e021710. DOI: 10.1161/JAHA.121.021710 8
Bjørkavoll- Bergseth et al North Sea Race Endurance Exercise Study 2018
were found at 3 hours between T0 and T1. The small-
est difference was at baseline between T1 and T2. 
Differences were highly significant at 3 hours among 
all groups (P<0.00005). At 24  hours, there was a 
significant difference between T0 and T1 and T0 and 
T2, but not between T1 and T2.
Multiple Regression Models
Multiple regression models were used to identify the 
predictors of the postexercise cTnI values after T1 
and T2 (Table 4). Following the CPX test (T1), baseline 
cTnI, maximal RPP, and maximal systolic blood pres-
sure were independent predictors of cTnI elevation 
at 3  hours. Following the race in 2018 (T2), baseline 
and cTnI response at identical time points of the race 
in 2013/2014 (T0) were the strongest predictors of the 
exercise- induced cTnI levels at both 3 and 24 hours. 
Duration of the race was an independent predictor of 
cTnI levels at 24 hours after the race but not at 3 hours.
DISCUSSION
This study demonstrates that the exercise- induced 
cTnI elevation is specific to each individual and that the 
individual cTnI level is strongly related to the workload 
and timing of sampling. These findings underscore 
that the exercise- induced cTn response needs to be 
interpreted in relation to the subject- specific response 




Difference P Value 95% CI
Baseline
T0– T1 5.1 0.18 −2.4 to 12.6
T0– T2 5.4 0.16 −2.1 to 12.9
T1– T2 0.3 0.95 −7.2 to 7.8
3 h after exercise
T0– T1 199.4 <0.0005 159.9 to 238.9
T0– T2 108.1 <0.0005 68.6 to 147.6
T1– T2 −91.3 <0.0005 −130.8 to −51.8
24 h after exercise
T0– T1 63.8 <0.00005 43.3 to 84.3
T0– T2 44.3 <0.00005 23.8 to 64.8
T1– T2 −19.5 0.06 −40.0 to 1.0
All 3 exercises (T1, T2, and T0) compared with a random intercept linear 
mixed- effects model. Expected differences with P value and 95% CI at 
corresponding time points between T0, T1, and T2. T0 indicates recruitment 
race; T1 cardiopulmonary exercise test 2018; and T2, 2018 race.
Table 4. Multiple Regression Analysis
cTnI 3 h After CPX Test (T1), 
R2=0.69 Nonstandardized Coefficients Standardized Coefficients
B SE β t P Value
Ln cTnI baseline T1 0.53 0.09 0.58 5.97 <0.001
Ln cTnI 3 h T2 0.34 0.10 0.32 3.29 <0.001
Systolic blood pressure maximum −0.01 0.00 −0.35 −2.12 0.04
Peak RPP 0.00 0.00 0.48 2.94 0.005
Duration of test −0.03 0.02 −0.18 −2.17 0.03
cTnI 24 h after CPX test (T1)  
R2=0.87
Ln cTnI baseline T1 0.72 0.10 0.73 7.53 <0.001
Ln cTnI 24 h T2 0.21 0.10 0.21 2.14 0.04
Male sex 0.21 0.11 0.10 1.88 0.07
cTnI 3 h after race 2018 (T2)  
R2=0.65
Ln cTnI 3 h T1 0.40 0.08 0.43 5.0 <0.001
Ln cTnI 3 h T0 0.48 0.08 0.54 6.28 <0.001
cTnI 24 h after race 2018 (T2)  
R2=0.83
Ln cTnI baseline T2 0.40 0.15 0.39 2.72 0.009
Ln cTnI 24 h T0 0.20 0.05 0.26 3.66 0.001
Ln cTnI 24 h T1 0.37 0.14 0.37 2.65 0.01
Male sex −0.26 0.15 −0.12 −1.76 0.08
Duration of the race −0.18 0.09 −0.13 −2.09 0.04
The table presents the multiple linear regression models using the backward elimination method. The models included predefined variables (age, sex, systolic 
blood pressure baseline, metabolic equivalent, hours, duration of exercise, cTnI at baseline), variables with a bivariate correlation P value <0.05 (Table 2), and 
the cTnI values at corresponding timepoints at CPX test 2018 (T1), 2018 race (T2), and the recruitment race (T0). CPX indicates cardiopulmonary exercise; cTnI, 
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to exercise, exercise workload, and timing of sampling 
following the exercise. These findings have implica-
tions for both clinical interpretation and future scientific 
studies exploring the exercise- induced cTn response. 
The present findings are particularly important for the 
differentiation between a physiological and pathologi-
cal response, emphasizing that knowledge of the prior 
exercise- induced cTn response and precise informa-
tion about workload (exercise intensity and duration) 
are necessary to generate reliable prediction models. 
These findings underscore the limitations in the inter-
pretation of cTn increase following exercise in a clinical 
setting, wherein information about prior cTn response 
and exercise workload are rarely available.
The increase in troponin following exercise has 
been demonstrated by numerous studies.3 In line with 
the previous studies, the present study demonstrates 
that cTnI levels relate to baseline cTn concentration, 
exercise intensity, and duration of exercise.10,21,22 
However, the precise relationship between workload 
and cTn elevation remains obscure. Figure 2 demon-
strates the close relationship between troponin re-
sponse and exercise intensity and duration, with the 
lowest postexercise cTnI levels following the CPX test 
(T1), higher following the race in 2018 (T2), and high-
est following the recruitment race (T0). The difference 
in cTnI levels following the 2 races (T0 and T2) re-
flects the higher exercise intensity in the recruitment 
race (T0) than in the 2018 race (T2). The race duration 
was shorter in the recruitment race (T0) than in the 
2018 race (T2), indicating a longer duration of high- 
intensity exercise in the recruitment race than in the 
2018 race. The primary reason for this difference in 
race duration relates to the study- related interference 
during the 2018 race. In 2018, all study individuals 
were stopped 4 times for blood pressure measure-
ments during the race. Although each pit stop lasted 
<2  minutes, most riders waited to join other riders 
coming up from behind. Because there was a ranking 
of participants in the race, subsequent groups were 
slower, thereby further reducing the duration of high- 
intensity exercise. This is underlined by the findings 
from the linear mixed- effects models. The expected 
differences in cTnI values increase with increasing ex-
ercise intensity and duration; the largest differences 
were at 3 hours after exercise between the first race, 
the second race, and the CPX test. These findings 
underscore the impact of exercise intensity and du-
ration on the cTnI response both at 3 and 24 hours 
following exercise. Although race duration is a surro-
gate for the duration of high- intensity exercise, it is a 
complex parameter that needs careful interpretation. 
Because there were no accurate measurements of 
heart rate or work during the first race, it is not pos-
sible to evaluate differences in the physical perfor-
mance in study participants between the recruitment 
race and the 2018 race (T0 and T2) accurately. Future 
studies need to incorporate repeated exercise with 
accurate measurements of workload to allow a better 
prediction of the relationship between repeated exer-
cise and cTn release.
Both during the CPX test and the 2018 race, there 
was a univariate correlation between cTnI and peak 
RPP following exercise. However, in multiple regres-
sion models, RPP remained an independent predictor 
of cTnI elevation only at 3 hours following exercise in 
the CPX test. When interpreting these results, it should 
be noted that peak RPP measurements from the 2018 
race have a drawback of uncertainty because blood 
pressure was measured at only 4 time points during 
the race. The use of more accurate tools, allowing more 
frequent monitoring of blood pressure during exercise, 
preferably without the need to interrupt the exercise, 
might provide better insights into the relationship be-
tween increased cardiac workload during exercise and 
exercise- induced cTn response.
Few studies have used multiple regression models 
to predict the exercise- induced cTn response.9,23– 25 
Several variables have been identified as indepen-
dent predictors of the cTnI response, including age,23 
duration of exercise,24 the intensity of exercise,8,22 
changes in creatinine,26 exercise experience,27 and 
systolic blood pressure.9 However, no study has used 
information from a previous exercise- induced cTn re-
sponse in the models. A common finding from the 
multiple regression models is that the models explain 
only a small proportion of the total variation in the cTn 
response to exercise, with an R2 ranging from 9% to 
44%.23,24 Compared with the previous studies, the 
present study found multiple regression models with 
far larger explanatory (R2) values ranging from 65% to 
87%. The model fit after adding information about the 
previous cTnI value (T0) in the multiple regression mod-
els was more evident following the race in 2018 (T2) 
than following the CPX test (T1). This might, in part, 
be explained by lesser exercise- induced cTnI elevation 
following the CPX test than the cTnI elevation following 
the 2 races (T0 and T2) (Figure 2).
The physiological mechanisms causing troponin re-
lease during exercise are largely unknown. It has been 
proposed that cTn elevation might be because of an in-
crease in preload, causing increased myocardial stretch 
and integrin- mediated transportation of cTn molecules 
across the intact myocyte membranes.28 However, 
in the present study, no difference in the echocardio-
graphic parameters was observed, and markers of de-
hydration (creatinine) did not explain the variation in the 
exercise- induced cTnI response in the multiple regres-
sion models. Circulating troponins levels are influenced 
by posttranslational modifications such as proteolytic 
degradation, phosphorylation, glycation, and acetyl-
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alter the circulating cTn molecules and influence the 
detection of cTn molecules by current assays. Notably, 
a recent study demonstrated the presence of smaller 
cTnT molecules released in healthy runners after a mar-
athon, compared with larger cTnT molecules released 
after acute myocardial infarction.30 This finding suggests 
that there might be changes in the molecular structure 
of circulating troponins when comparing exercise with 
ischemic injury. It remains to be determined whether 
there are also changes in the molecular structure of cTnI 
that can explain the large individual differences in the 
exercise- induced cTnI response.
Strengths and Limitations
The strengths of this study are the extensive data 
and the measurement of high- sensitivity cTnI at differ-
ent exercise loads and time points separated by >4 
years. Normal echocardiographic findings and the 
absence of coronary pathology on repeated coro-
nary computed tomography angiography ensured 
that the cause of cTnI elevation was not related to the 
abnormal cardiac function or obstructive coronary ar-
tery disease. Although the study subjects were well- 
trained participants from a selected cohort, age, sex, 
and physical characteristics are representative of an 
average recreational athlete. The recruitment of well- 
trained subjects in the present study ensures that 
exercise- performance was not limited by factors such 
as muscular capacity or technical skills.
Several limitations apply to the present study. 
First, this is an observational study with study sub-
jects reflecting a highly selective cohort. Second, as 
discussed above, there are no additional data except 
the race duration to evaluate exercise intensity from 
the recruitment race (T0). Hence, it is not possible to 
make an accurate comparison of difference in race in-
tensity between the recruitment (T0) and the 2018 race 
(T2). The exercise- induced cTnI response was only fol-
lowed for 24 hours. We have previously reported that 
prolonged release of cTnI might be associated with a 
pathological cTnI response.5 It would be of interest to 
study the reproducibility of the duration of the cTnI ele-
vation beyond 24 hours following exercise.
CONCLUSIONS
The present study shows that there are large but 
reproducible differences in the magnitude of the 
exercise- induced cTnI responses among individuals. 
The exercise- induced cTnI response reflects exercise 
intensity and duration in a person- specific manner. 
This finding underscores the need to consider both 
workload, timing of sampling, and earlier cTnI response 
when attempting to differentiate physiological from a 
pathological cTnI response to exercise. These findings 
have important implications for the interpretation of 
postexercise cTnI values and for the future design of 
studies evaluating the exercise- induced cTnI response.
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Cardiopulmonary exercise (CPX) test  
All study participants were tested on their personal bikes fitted to a Cyclus 2 electronically braked 
ergotrainer (RBM elektronik-automation; Leipzig, GER)14. Each participant performed a 10-minute 
warm-up before exercise tests, resistance was kept low and was guided by the test-leader. The lactate 
threshold test was executed as a 4-minute incremental load stepwise test. The workload was based on 
previous training history and results from warm-up (min 50w – maximum 220w). The workload was 
increased with fixed individualized (min 15w – maximum 30w) steps every fourth minute.  Lactate 
was measured in capillary blood from the participants' index finger on the Lactate Scout+ (EKF 
Diagnostic, Cardiff, GB). Gas exchange was measured breath by breath on a Jaeger Vyntus CPX 
(Carefusion, Hoechberg, GE). Lactate threshold was defined as a lactate value > 1.5 mmol/l above 
mean value from step 1 and 2 or a RER > 1.0. For each step, including rest and warm-up, the 
following variables were collected; Work (watt), blood pressure (mmHg), VO2 (ml/min/kg), RER, 
Lactate, and heart rate (bpm). Following the stepwise determination of lactate threshold, participants 
were allowed a maximum of 5-minute cooldown, before performing the VO2max test. The VO2max test 
was a ramp protocol started at 70-250 (min-max) watts with an increase in the workload of 15-32 
(min-max) Watt/min until exhaustion. The VO2max test was performed to reach maximum effort 
between 5 and 10 minutes. Pre-test blood pressure was obtained at the start of the test and maximal 
blood pressure was obtained immediately after the end of the test with the participant still seated on 
the bike. VO2max was defined as the point where VO2 reached a plateau despite increasing resistance. 
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Figure S1. Race profile, altitude outlined.  
 
 
Points of blood pressure measurements marked. Diagram exported from the Garmin Connect website 
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